Vliwazell Pro wound dressing follow-up for real-world use
Official title: Prospective Systematic Data Collection for Post-Marketing Surveillance of Vliwazell® Pro Wound Dressing
Run by Lohmann & Rauscher · NCT07316556 · Data updated 2026-11-12
This follow-up will see if Vliwazell Pro safely controls wound fluid and protects the skin around acute and chronic wounds in adults who need a high-absorbency dressing.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 208 (estimated) |
| Sponsor | Lohmann & Rauscher Industry-sponsored |
| Locations | 8 sites (Aachen and 7 other locations) |
| Status | Recruiting |
| Started | March 11, 2024 |
| Main results expected | January 31, 2027 |
| Study ends | January 31, 2027 |
| Registry record updated | January 5, 2026 |
| Trial ID | NCT07316556 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with superficial acute or chronic wounds that produce moderate to very high amounts of exudate—such as venous, arterial, diabetic, pressure, post‑operative, oncologic wounds, or donor sites—who can give informed consent are ideal candidates.
✕Probably not a fit
Patients under 18, those with a known allergy to any dressing component, or patients with tunnel-forming wound pockets (a contraindication) are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This post-marketing, observational follow-up collects real-world data on the performance and safety of the Vliwazell Pro superabsorbent dressing during routine wound care. Clinicians will record wound characteristics such as exudate level, odor, and condition of the surrounding skin, along with any device-related adverse events. The study also gathers patient and healthcare provider satisfaction and documents dressing change frequency in everyday practice. No experimental interventions are assigned; the product is used according to its intended indications and standard care.
Why it matters
Potential benefit: If successful, the dressing could reduce the need for frequent changes, protect surrounding skin from maceration, and make wound care more convenient and comfortable for patients.
How similar studies have gone: Similar superabsorbent dressings have shown benefit in reducing maceration and dressing-change frequency in prior real-world and clinical reports, though product-specific post-market data for Vliwazell Pro are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Wound according to indication mentioned in the instructions for use: 1. Superficial acute and chronic wounds with moderate to very high amounts of exudate and that are superficial, in: * arterial and venous ulcers * diabetic ulcers * pressure ulcers * post-traumatic wounds * post-operative wounds healing by secondary intention * skin graft donor sites * oncological wounds * ulcerating tumors * wounds at risk of infection * superficial 2nd degree burns * lymphatic wounds 2. As secondary dressing on laparotomy wounds and fistulas or for deep wounds when used with appropriate wound filler 3. Patient has full legal capacity 4. Patient is able to understand and provide information 5. Patient has signed the written Informed Consent Form Exclusion Criteria: 1. Age \< 18 years 2. Patient with contraindication: * Known allergy and/or hypersensitivity to any of the product components. * Not for use in tunnel-forming wound pockets, as the product may expand considerably with the absorption of wound exudate. * Not for use on dry wounds. 3. Pregnant or lactating women 4. Patients participating in another clinical trial at the time of inclusion 5. Patient not covered by health insurance/social security
Where it's running
-
Wundmanagement
Aachen, Germany Recruiting -
MVZ Hausärzte
Brüggen, Germany Recruiting -
ORGAMed
Dortmund, Germany Recruiting -
Hautklinik
Erlangen, Germany Recruiting -
Krankenhaus Tabea
Hamburg, Germany Recruiting -
Gesundheitsmanager, Inh. Christine Bertram
Waidhaus, Germany Recruiting
Show 2 more locations
-
WKM Rösner Mönchengladbach
Mönchengladbach, Germany Not yet recruiting -
WKM Rösner Willich
Willich, Germany Not yet recruiting
Study contacts
- Principal investigator: Thomas Eberlain, Dr — Lohmann & Rauscher
- Study coordinator: Uta Brunner
- Email: project@brunner-memmhardt.de
- Phone: +49 (0) 6732-600 8624
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Topical GHK-Cu gel to speed healing of small skin wounds
This test will see if applying a daily GHK‑Cu gel helps small punch‑biopsy skin wounds heal faster in healthy adults.
-
Miro3D Wound Matrix for Diabetic Foot Ulcers
This study tests whether adding Miro3D Wound Matrix to standard care helps healing diabetic foot ulcers in adults.
-
THERAVEX Tissue Care Spray Plus for Healing of Skin Wounds and Ulcers
This observational review tests whether THERAVEX Tissue Care Spray Plus, used with standard wound care, helps heal various skin wounds and chronic ulcers in adults.
-
See if Hyalomatrix helps heal venous leg ulcers faster when added to standard care
This trial tests whether adding Hyalomatrix to standard wound care helps people with venous leg ulcers heal more effectively.
-
Using Miro3D Wound Matrix to Heal Complex Wounds
This study is testing if a new wound treatment made from pig liver can help heal tough wounds and reduce pain for adults with chronic ulcers and other serious skin issues.
-
Psychological support for patients undergoing VSD drainage surgery for chronic wounds
This study is testing whether adding psychological support to the care of patients having VSD drainage surgery for chronic wounds can help them feel better emotionally and recover faster.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.